Floatz logo

29 assets in Gallbladder Cancer

Therapeutic assets addressing Gallbladder Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Fluorouracilum
Gallbladder Cancer
Lisata Therapeutics, Inc.P2BBB (72)
Capecitabine
Gallbladder Cancer
Merck Sharp & Dohme LLCP3BB (70)
Oxaliplatin
Gallbladder Cancer
Tianjin Medical University Cancer Institute and HospitalP3BB (68)
Cyclophosphamide
Gallbladder Cancer
Merck Sharp & Dohme LLCP2BB (65)
Docetaxel
Gallbladder Cancer
Merck Sharp & Dohme LLCP2BB (65)
Epirubicin
Gallbladder Cancer
Merck Sharp & Dohme LLCP2BB (65)
Carboplatin
Gallbladder Cancer
Merck Sharp & Dohme LLCP2BB (64)
Cis-Diamminedichloroplatinum Ii
Gallbladder Cancer
Lisata Therapeutics, Inc.P2BB (64)
Trastuzumab
Gallbladder Cancer
Cancer Research UKP2/3BB (64)
Pembrolizumab
Gallbladder Cancer
Merck Sharp & Dohme LLCP2B (63)
Atezolizumab
Gallbladder Cancer
TransThera Sciences (Nanjing), Inc.P2B (62)
Durvalumab
Gallbladder Cancer
Lisata Therapeutics, Inc.P2B (60)
Lenvatinib
Gallbladder Cancer
Tianjin Medical University Cancer Institute and HospitalP2B (57)
Nivolumab
Gallbladder Cancer
Instituto do Cancer do Estado de São PauloP2B (57)
Pembrolizumab/Vibostolimab Coformulation
Gallbladder Cancer
Merck Sharp & Dohme LLCP2B (57)
Pertuzumab
Gallbladder Cancer
Cancer Research UKP2/3B (57)
Tinengotinib
Gallbladder Cancer
TransThera Sciences (Nanjing), Inc.P1/2CCC (55)
Cobimetinib
Gallbladder Cancer
National Cancer Institute (NCI)P2CCC (53)
Toripalimab
Gallbladder Cancer
Tianjin Medical University Cancer Institute and HospitalP2CCC (53)
Certepetide
Gallbladder Cancer
Lisata Therapeutics, Inc.P2CCC (49)
Rezatapopt
Gallbladder Cancer
PMV Pharmaceuticals, IncP1/2CC (47)
Tivozanib
Gallbladder Cancer
University of FloridaP1/2CC (47)
Avelumab
Gallbladder Cancer
National Cancer Institute (NCI)P1/2CC (45)
Immunoglobulin G1, Anti-(Human Cd Antigen Cd27) (Human Monoclonal Cdx-1127 Clone 1F5 Heavy Chain), Disulfide With Human Monoclonal Cdx-1127 Clone 1F5 .Kappa.-Chain, Dimer
Gallbladder Cancer
National Cancer Institute (NCI)P2CC (44)
Acc-1898
Gallbladder Cancer
AccSalus Biosciences, Inc.P1CC (43)
Guadecitabine
Gallbladder Cancer
University of Southern CaliforniaP1CC (43)
Recombinant Ephb4-Hsa Fusion Protein
Gallbladder Cancer
University of Southern CaliforniaP1CC (42)
Copper Cu 64 Anti-Cea Monoclonal Antibody M5A
Gallbladder Cancer
City of Hope Medical CenterN/AD (30)